Miltefosine
Generic name: Miltefosine
Brand names: Impavido
Dosage form: oral capsule (50 mg)
Drug class:
Anthelmintics
Usage of Miltefosine
Miltefosine is an anti-parasitic drug used to treat leishmaniasis, a disease caused by an infection with parasites that enter the body through the bite of an infected sand fly.
Miltefosine is used to treat leishmaniasis affecting the skin, internal organs (such as the liver, spleen or bone marrow), and mucous membranes (nose, mouth, and throat).
Miltefosine may also be used for purposes not listed in this medication guide.
Miltefosine side effects
Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Miltefosine may cause serious side effects. Call your doctor at once if you have:
Common side effects of miltefosine may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Miltefosine
You should not use miltefosine if you are allergic to it, or if you have:
To make sure miltefosine is safe for you, tell your doctor if you have:
In animal studies, miltefosine caused birth defects and death of unborn offspring, and also affected fertility in male and female adults. It is not known whether these effects would occur in people using miltefosine. Ask your doctor about your risk.
FDA pregnancy category D. You should not use miltefosine if you are pregnant. You may need to have a negative pregnancy test before starting this treatment. Use effective birth control while you are taking miltefosine and for at least 5 months after your treatment ends.
Vomiting or diarrhea caused by miltefosine can make birth control pills less effective. Ask your doctor about using non hormonal birth control (condom, diaphragm with spermicide) to prevent pregnancy if you have vomiting and/or diarrhea while taking miltefosine.
If you become pregnant, your name may be listed on a pregnancy registry. This is to track the outcome of the pregnancy and to evaluate any effects of miltefosine on the baby.
It is not known whether miltefosine passes into breast milk or if it could harm a nursing baby. You should not breast-feed while using miltefosine, and for at least 5 months after your treatment ends.
Miltefosine should not be given to a child younger than 12 years old.
Relate drugs
- Albendazole
- Albenza
- Ascarel
- Biltricide
- Egaten
- Emverm
- Impavido
- Ivermectin
- Ivermectin (Oral)
- Mebendazole
- Miltefosine
- Niclosamide
- Pamix
- Pin-Away
- Pin-X
- Pinworm
- Pinworm Medicine
- Piperazine
- Praziquantel
- Pyrantel
- Stromectol
- Triclabendazole
- Vermox
How to use Miltefosine
Usual Adult Dose for Leishmaniasis:
Weight 30 to 44 kg: 50 mg orally twice a dayWeight at least 45 kg: 50 mg orally 3 times a dayDuration of therapy: 28 consecutive daysUses: For the treatment of:-Visceral leishmaniasis due to Leishmania donovani-Cutaneous leishmaniasis due to L braziliensis, L guyanensis, and L panamensis-Mucosal leishmaniasis due to L braziliensis
Usual Pediatric Dose for Leishmaniasis:
12 years or older:-Weight 30 to 44 kg: 50 mg orally twice a day-Weight at least 45 kg: 50 mg orally 3 times a dayDuration of therapy: 28 consecutive daysUses: For the treatment of:-Visceral leishmaniasis due to L donovani-Cutaneous leishmaniasis due to L braziliensis, L guyanensis, and L panamensis-Mucosal leishmaniasis due to L braziliensis
Warnings
In animal studies, miltefosine has caused birth defects and death of unborn offspring. It is not known whether these effects would occur in people. You should not use miltefosine if you are pregnant.
You may need to have a negative pregnancy test before starting this treatment. Use effective birth control while you are taking miltefosine and for at least 5 months after your treatment ends.
What other drugs will affect Miltefosine
Other drugs may interact with miltefosine, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell each of your health care providers about all medicines you use now and any medicine you start or stop using.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions